NF1

Clinical trials for NF1 explained in plain language.

Never miss a new study

Get alerted when new NF1 trials appear

Sign up with your email to follow new studies for NF1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Promising drug may shrink inoperable tumors in kids with rare genetic condition

Disease control Ongoing

This study tests an experimental drug called selumetinib in children and young adults (ages 3-18) with neurofibromatosis type 1 (NF1) who have nerve tumors that cannot be removed by surgery. The goal is to see if the drug can shrink the tumors or stop them from growing. Participa…

Matched conditions: NF1

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 29, 2026 00:35 UTC

NF1

Get alerted when new NF1 trials appear

Promising drug may shrink inoperable tumors in kids with rare genetic condition